Media Highlights: Alliance for Hippocratic Medicine v. FDA
Several leaders from the Center for Reproductive Rights have been interviewed about Alliance for Hippocratic Medicine v. FDA. Below are media highlights.
Broadcast Media Highlights
Print and Online Media Highlights
- “Medication abortion access hangs in balance as appeals court hears mifepristone case,” MarketWatch, 05.17.23
- “Mifepristone and Judicial Whiplash,” Broken Law, American Constitution Society, 04.25.23
- “‘A New Jane Crow’: Abortion Advocates Brace for Supreme Court Ruling That Could Ban Mifepristone,” Democracy Now, 04.20.23
- “Supreme Court Lets Abortion Pill Remain on Market for Two More Days,” The Wall Street Journal, 04.19.23
- “Supreme Court delays decision in abortion drug case until Friday,” The Independent, 04.19.23
- “Supreme Court preserves FDA rules for access to abortion pill—but only temporarily,” The Independent, 04.14.23
- “‘No drug is safe’: Mifepristone court battle could threaten access to other FDA-approved drugs,” USA Today, 04.14.23
- “Amarillo Judge’s Ruling Could Lead to Nationwide Ban on Abortion Pills,” The Austin Chronicle, 04.14.23
- “Advocates Warn Abortion Pill Access Still at ‘Severe Risk’ Despite Supreme Court Reprieve,” Common Dreams, 04.14.23
- “Appeals court keeps abortion pill on shelves but limits use,” Courthouse News Service, 04.13.23
- “Abortion pill ruling: will the US supreme court hear another abortion case?” The Guardian, 04.13.23
- “Democratic leaders warn abortion pill ruling could endanger other FDA-approved drugs,” Highland County Press, 04.12.23
- “A judge’s ruling threatens access to a common abortion drug. What does that mean for Texas?” Texas Standard, 04.12.23
- “A Right-Wing Judge Said The FDA Shouldn’t Have Approved The Abortion Pill. What Now?” HuffPost, 04.11.23
- “A Conservative Christian Judge Rules Against Medication Abortion. How Hard Will Democrats Fight Back?” The Nation, 04.11.23
- “A judge’s ruling threatens access to a common abortion drug. What does that mean for Texas?” KERA News, 04.11.23
- “Democratic leaders warn abortion pill ruling could endanger other FDA-approved drugs,” KTTN, 04.11.23
- “Two separate court rulings throws the future of abortion medication into uncertainty,” NM Political Report, 04.11.23
- “6 burning questions about how the FDA will handle conflicting abortion pill decisions,” STAT News, 04.11.23
- “Abortion pill alternative: The drug that could be used if Texas ban on mifepristone upheld,” CNBC, 04.11.23
- “Abortion Pill Ruling Could Threaten Vaccines, Contraception, Advocates Say,” Daily Beast, 04.10.23
- “Abortion rights groups condemn ‘reckless’ judge overseeing critical drug case: ‘Minority rule at its worst,’” The Independent, 04.10.23
- “Abortion could be headed to the Supreme Court, again,” News Not Noise, 04.10.23
- “Biden White House will fight, not ignore, abortion pill ruling suspending mifepristone,” USA Today, 04.10.23
- “Democratic leaders warn abortion pill ruling could endanger other FDA-approved drugs,” Idaho Capital Sun, 04.09.23
- “Matthew Kacsmaryk: Who is the Trump-appointed judge trying to ban abortion drug?” The Independent, 04.09.23
- “Dueling federal rulings plunge future of abortion pill into legal uncertainty,” USA Today, 04.08.23
- “‘What next?’ Schumer lambasts Texas judge’s abortion pills ruling,” The Guardian, 04.08.23
- “Ultra-Conservative Texas Judge Halts FDA Approval of Abortion Pill,” Daily Beast, 04.08.23
- “US abortion pill ruling: what happened and what’s next?” The Guardian, 04.07.23
- “Trump-appointed judge blocks approval of widely used abortion drug in decision that threatens access nationwide,” The Independent, 04.07.23
- “Nessel: Despite federal ruling, abortion medication remains legal in Michigan,” Detroit Free Press, 04.07.23
- “Supreme Court Seems Inclined to Reject Bid to Curtail Abortion Pill Access,” New York Times, 03.26.24
- “Why the scope of the Supreme Court’s abortion pill case matters,” MSNBC, 03.26.24